Lavender Aromatherapy for Anxiety During Urodynamics

Sponsor
University of Southern California (Other)
Overall Status
Completed
CT.gov ID
NCT02344745
Collaborator
(none)
80
1
2
10
8

Study Details

Study Description

Brief Summary

Urodynamics are performed in the evaluation of urinary incontinence in women considering surgery or who have failed conservative therapies. Urodynamic testing requires the placement of small catheters into the bladder and the vagina or rectum. Many women experience anxiety around the procedure which can affect patient satisfaction. Lavender aromatherapy has been associated with decreased anxiety in a variety of clinical situations. The purpose of this study is to determine a difference in self-reported anxiety and pain levels before, during, and after multichannel urodynamics in patients given lavender aromatherapy versus placebo. This study design is a randomized control trial. Women scheduled for urodynamic testing at the Los Angeles County University of Southern California (LAC+USC) Urogynecology clinic will be invited to participate. Participants will be randomized to the aromatherapy or the placebo group after informed consent is obtained and immediately before undergoing multichannel urodynamics. The participants will complete the Hospital Anxiety and Depression Survey (HADS) at baseline. They will be asked to rate their level of anxiety and pain before, during, and 15 min after the study using the visual analogue scale and Wong-Baker pain scale. At the end the participants will also be asked to rate their satisfaction with the visit overall. The primary endpoint is defined as anxiety immediately after catheters are placed. Data will be entered into a coded database for analysis using the independent samples t test, the Mann-Whitney U test, and the chi square test. Intention to treat analysis will be used.

Condition or Disease Intervention/Treatment Phase
  • Other: Lavandula angustifolia essential oil (Aura Cacia)
  • Other: Distilled water
N/A

Detailed Description

This study design is a randomized placebo control trial.

Aside from randomization to aromatherapy versus placebo, no procedures will be performed for study purposes that would not be normally performed in the clinical evaluation.

Women scheduled for urodynamic testing at the Los Angeles County University of Southern California (LAC+USC) Urogynecology clinic will be invited to participate. Participants who meet inclusion criteria will be randomized to the aromatherapy or the placebo group after informed consent is obtained and immediately before undergoing multichannel urodynamics. Sequentially numbered sealed opaque envelopes containing the identity of the study arm will be used for randomization. The urogynecology clinic nurse will prepare the aromatherapy versus distilled water on the paper towel that the patient is routinely given to hold over their mouths when asked to cough during the procedure; two drops of each will be utilized. Before the physician comes in, the nurse will ask the participant to take a deep breath while holding the towel 3 inches from her face and will instruct the participant to continue to take normal breaths subsequently. It will not be possible to blind the participants or the examiner to the assigned group since the lavender oil will have a different scent than the placebo. However, the use of distilled water on the towel will allow the possibility that the deep breathing accompanying the instruction may have an effect on reported pain and anxiety.

The participant will undergo the standard clinic exam in standardized order. The participants will complete the Hospital Anxiety and Depression Survey (HADS) at baseline. The HADS is reliable instrument for detecting states of depression and anxiety in the setting of a hospital medical outpatient clinic; it is available in English and Spanish versions. This will be used to establish their baseline anxiety levels. Participants will then be asked to rate their level of anxiety and pain immediately before beginning the exam, immediately after catheter placement, and 15 min after termination of the study using a 10 point visual analogue scale and the Wong-Baker pain scale.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Treatment
Official Title:
The Use of Lavender Aromatherapy to Decrease Women's Anxiety and Perception of Pain During Multi-channel Urodynamics Procedure
Study Start Date :
Oct 1, 2014
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control

Distilled water

Other: Distilled water
The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.

Experimental: Lavender

Lavandula angustifolia essential oil (Aura Cacia)

Other: Lavandula angustifolia essential oil (Aura Cacia)
The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.

Outcome Measures

Primary Outcome Measures

  1. Anxiety Measured by VAS [At the time of catheter placement]

    Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Higher values indicate more anxiety.

Secondary Outcome Measures

  1. Wong Baker Pain Scale [At the time of catheter placement]

    Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.

  2. Anxiety Measured by VAS [15 min after removal of the urodynamics catheters]

    Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Higher values indicate more anxiety.

  3. Wong Baker Pain Scale [15 min after removal of the urodynamics catheters]

    Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women aged 18 and over,

  • Scheduled to undergo multichannel urodynamic study,

  • Able to give informed consent,

  • Able to read and write in English or Spanish,

  • Anxiety score > 0 on numerical scale at baseline

Exclusion Criteria:
  • Any contraindication to multichannel urodynamic study (active urinary tract infection, active pelvic infection, glucosuria, severe hypertension, or any other condition that might be worsened by an uncomfortable test),

  • Allergy to lavender oil, or any of its components

Contacts and Locations

Locations

Site City State Country Postal Code
1 Los Angeles Count + USC Medical Center Los Angeles California United States 90033

Sponsors and Collaborators

  • University of Southern California

Investigators

  • Principal Investigator: Begum Ozel, M.D., University of Southern California

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Begum Ozel, Assistant Professor, University of Southern California
ClinicalTrials.gov Identifier:
NCT02344745
Other Study ID Numbers:
  • HS-14-00444
First Posted:
Jan 26, 2015
Last Update Posted:
Dec 16, 2016
Last Verified:
Oct 1, 2016
Keywords provided by Begum Ozel, Assistant Professor, University of Southern California
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Control Lavender
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.
Period Title: Overall Study
STARTED 40 40
COMPLETED 38 40
NOT COMPLETED 2 0

Baseline Characteristics

Arm/Group Title Control Lavender Total
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Total of all reporting groups
Overall Participants 38 40 78
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
48.0
(7.5)
49.0
(8.0)
48.5
(7.9)
Gender (Count of Participants)
Female
38
100%
40
100%
78
100%
Male
0
0%
0
0%
0
0%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
37
97.4%
39
97.5%
76
97.4%
Not Hispanic or Latino
1
2.6%
1
2.5%
2
2.6%
Unknown or Not Reported
0
0%
0
0%
0
0%
Anxiety (cm) [Median (Full Range) ]
Median (Full Range) [cm]
4
5
5
Pain (units on a scale) [Median (Full Range) ]
Median (Full Range) [units on a scale]
0
0
0

Outcome Measures

1. Primary Outcome
Title Anxiety Measured by VAS
Description Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Higher values indicate more anxiety.
Time Frame At the time of catheter placement

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Control Lavender
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.
Measure Participants 38 40
Median (Full Range) [cm]
4
3
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Control, Lavender
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value 0.08
Comments
Method Wilcoxon (Mann-Whitney)
Comments
2. Secondary Outcome
Title Wong Baker Pain Scale
Description Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.
Time Frame At the time of catheter placement

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Control Lavender
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.
Measure Participants 38 40
Median (Full Range) [units on a scale]
0
0
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Control, Lavender
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value 0.70
Comments
Method Wilcoxon (Mann-Whitney)
Comments
3. Secondary Outcome
Title Anxiety Measured by VAS
Description Anxiety was measured using a visual analogue scale, from 0-10 cm. All measurements were rounded to the nearest 0.5 cm. Higher values indicate more anxiety.
Time Frame 15 min after removal of the urodynamics catheters

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Control Lavender
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.
Measure Participants 38 39
Median (Full Range) [cm]
0.5
0
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Control, Lavender
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value 0.001
Comments
Method Wilcoxon (Mann-Whitney)
Comments
4. Secondary Outcome
Title Wong Baker Pain Scale
Description Pain was measured on the Wong Baker scale from 0-10. Higher values indicate more pain.
Time Frame 15 min after removal of the urodynamics catheters

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Control Lavender
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.
Measure Participants 38 39
Median (Full Range) [units on a scale]
0
0
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Control, Lavender
Comments
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value 0.50
Comments
Method Wilcoxon (Mann-Whitney)
Comments

Adverse Events

Time Frame The participants were observed for 60 minutes after administration of aromatherapy.
Adverse Event Reporting Description
Arm/Group Title Control Lavender
Arm/Group Description Distilled water Distilled water: The participants will be instructed to take a deep breath while holding the towel with two drops of distilled water 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure. Lavandula angustifolia essential oil (Aura Cacia) Lavandula angustifolia essential oil (Aura Cacia): The participants will be instructed to take a deep breath while holding the towel with two drops of essential oil 3 inches from her face before the start of the procedure and will be instructed to continue to take normal breaths subsequently during the procedure.
All Cause Mortality
Control Lavender
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Control Lavender
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/40 (0%) 0/40 (0%)
Other (Not Including Serious) Adverse Events
Control Lavender
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/40 (0%) 0/40 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Begum Ozel, M.D.
Organization Keck School of Medicine
Phone 323-226-3416
Email ozel@usc.edu
Responsible Party:
Begum Ozel, Assistant Professor, University of Southern California
ClinicalTrials.gov Identifier:
NCT02344745
Other Study ID Numbers:
  • HS-14-00444
First Posted:
Jan 26, 2015
Last Update Posted:
Dec 16, 2016
Last Verified:
Oct 1, 2016